Salus acquires 49% of Croatian Medorion
Ljubljana, 18 July - Salus, a wholesaler of medications and medical equipment, completed a purchase of a 49% stake in Medorion on Monday, which gives Salus control over the Croatian company, which holds a marketing authorisation for treatments of rare diseases.
The rest of this news item is available to subscribers.
The news item consists of 678 characters (without spaces) or 132 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.